About Rephine
Rephine is a Healthcare company based in Barcelona (Spain) founded in 1997, and was acquired by RepRephinehine in July 2022. Rephine is recognized for quality assurance in life sciences. It operates on a Professional Services and Subscription Services model. Its chief executive, as recorded, is Octavi Colomina. Rephine offers products and services including GMP Audit Services, GxP Consultancy, and Global Audit Library. Its focus areas include Pharmaceuticals, Quality Assurance Services, Medical Devices and Compliance Solutions. Its legal entity is Rephineâ„¢.
Company details
Rephine is established as a leader in quality assurance and GxP compliance for the life sciences industry, including pharmaceutical, biotech, and medical device sectors. Services are provided globally across the product development lifecycle, from raw materials to patient delivery. Solutions such as GMP audit services, GxP consultancy, and a comprehensive global audit library are offered to ensure compliance and quality in manufacturing supply chains. Support is extended to digital transformation and tailored medical device compliance, maintaining high standards through bespoke audits and readiness assessments.
- Headquarters Barcelona, Spain
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website tdvct.com
- Social LinkedIn
- Acquired by RepRephinehine (Jul 2022)
- Legal Name Rephine™
- Investors
- Acquired byRepRephinehine
(Jul 2022)
Products & Services of Rephine
Rephine offers a comprehensive portfolio of products and services, including GMP Audit Services, GxP Consultancy, and Global Audit Library.
Audits are conducted for pharmaceutical supply chain compliance.
Consultancy is provided for manufacturing and compliance readiness.
Reports on manufacturing sites are offered for purchase.
Investors in Rephine
Rephine has secured backing from 1 investor. Prominent investors backing the company include RepRephinehine.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical and regulatory consulting services are provided to pharmaceutical clients. | 1998 | rephine.com | Stevenage, United Kingdom |
Investor details for Rephine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Rephine
1 people are tracked at Rephine (1 in leadership).
| Name | Role | Group |
|---|---|---|
Octavi Colomina | CEO | Leadership |
Complete people profiles for Rephine
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Rephine
2 dated milestones of Rephine across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Rephine is founded.
- Exit Acquired by RepRephinehine.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rephine
Rephine was founded in 1997.
Rephine is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Octavi Colomina is the CEO of Rephine, as recorded in our data.
Rephine is established as a leader in quality assurance and GxP compliance for the life sciences industry, including pharmaceutical, biotech, and medical device sectors. Services are provided globally across the product development lifecycle, from raw materials to patient delivery. Solutions such as GMP audit services, GxP consultancy, and a comprehensive global audit library are offered to ensure compliance and quality in manufacturing supply chains. Support is extended to digital transformation and tailored medical device compliance, maintaining high standards through bespoke audits and readiness assessments.
Rephine offers GMP Audit Services, GxP Consultancy, and Global Audit Library.
Rephine has 1 investor. Key investors include RepRephinehine.
Rephine operates through Rephineâ„¢.
Yes. Rephine was acquired by RepRephinehine in July 2022.